Healthy subjects
Conditions
Interventions
None listed
Sponsors
HUMA R&D CORP
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Japanese males and females who are aged 20 years or over and less than 80 years at the time of written informed consent. 2.Subjects who are fully explained the purpose and details of the study, have ability to consent, are volunteering to participate in the study with a full understanding of the explanation, and have consented to participate in the study in writing.
Exclusion criteria
Exclusion criteria: 1.Subjects diagnosed with dementia-related disease by a physician or through health checkups, etc. or subjects with suspected dementia. 2.Subjects receiving medication or outpatient treatment for a serious disease. 3.Subjects receiving exercise or diet therapy under the supervision of a physician. 4.Subjects with current or previous history of drug dependence or alcohol dependence. 5.Subjects who are currently seeing a doctor for the treatment of a psychiatric disorder (e.g., depression) and/or sleep disorder (e.g., insomnia, sleep apnea syndrome) or have previous history of a psychiatric disorder. 6.Night or shift workers with irregular life patterns. 7.Subjects whose eating, sleeping, and other habits are extremely irregular. 8.Subjects who are having a very unbalanced diet. 9.Subjects with current or previous history of a brain disease, malignancy, immunological disease, diabetes mellitus, hepatic disease (hepatitis), renal disease, cardiac disease, thyroid disease, adrenal disease, metabolic disease, or other serious diseases. 10.Subjects who are unable to stop using, throughout the study period, products that may impact brain function (working memory), such as foods for specified health uses, foods with functional claims, health foods (including supplements), drugs, and quasi-drugs (ingredient: theanine, caffeine, polyphenol, soybean lecithin, DHA/EPA, taurine, ginkgo leaf, etc.). 11.Subjects who are participating in other clinical trials at the time of obtaining consent, and who plan to participate in other clinical trials within 4 weeks from the end of the study to the start of the main study of the study, or during the study. 12.Women who are currently pregnant or breastfeeding, or may become pregnant or start breastfeeding during the study period. 13.Subjects who have difficulty complying with recording of each survey form.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Communication evaluation | — |
Secondary
| Measure | Time frame |
|---|---|
| Cognitive function test, Other questionnaire | — |
Countries
Japan
Contacts
Public ContactHidemasa Toya
HUMA R&D CORP Clinical Development Department
Outcome results
None listed